# ESAB Corp: financial statements, quarterly

ESAB · NYSE · CIK 1877322 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esab.md) · [Financials](/companies/esab/financials.md) · [Filings](/companies/esab/filings.md) · [Insiders](/companies/esab/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/esab/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [681](/filings/0001877322-24-000138.md) | [689 d](/filings/0001877322-26-000007.md) | [690](/filings/0001877322-25-000084.md) | [707](/filings/0001877322-25-000134.md) | [673](/filings/0001877322-25-000152.md) | [671 d](/filings/0001877322-26-000007.md) | [678](/filings/0001877322-26-000033.md) | [716](/filings/0001877322-26-000056.md) | [728](/filings/0001877322-25-000152.md) | [721 d](/filings/0001877322-26-000007.md) | [746](/filings/0001877322-26-000033.md) | [808](/filings/0001877322-26-000056.md) |
| Cost of revenue | $m | [431](/filings/0001877322-24-000138.md) | [435 d](/filings/0001877322-26-000007.md) | [435](/filings/0001877322-25-000084.md) | [437](/filings/0001877322-25-000134.md) | [419](/filings/0001877322-25-000152.md) | [412 d](/filings/0001877322-26-000007.md) | [423](/filings/0001877322-26-000033.md) | [450](/filings/0001877322-26-000056.md) | [459](/filings/0001877322-25-000152.md) | [463 d](/filings/0001877322-26-000007.md) | [470](/filings/0001877322-26-000033.md) | [500](/filings/0001877322-26-000056.md) |
| Gross profit | $m | [250](/filings/0001877322-24-000138.md) | [255 d](/filings/0001877322-26-000007.md) | [255](/filings/0001877322-25-000084.md) | [270](/filings/0001877322-25-000134.md) | [254](/filings/0001877322-25-000152.md) | [258 d](/filings/0001877322-26-000007.md) | [255](/filings/0001877322-26-000033.md) | [266](/filings/0001877322-26-000056.md) | [269](/filings/0001877322-25-000152.md) | [258 d](/filings/0001877322-26-000007.md) | [275](/filings/0001877322-26-000033.md) | [307](/filings/0001877322-26-000056.md) |
| Research and development | $m | [9.0](/filings/0001877322-24-000138.md) | [10.7 d](/filings/0001877322-26-000007.md) | [10.1](/filings/0001877322-24-000088.md) | [9.7](/filings/0001877322-25-000134.md) | [9.2](/filings/0001877322-25-000152.md) | [10.2 d](/filings/0001877322-26-000007.md) | [10.1](/filings/0001877322-26-000033.md) | [10.5](/filings/0001877322-26-000056.md) | [10.5](/filings/0001877322-25-000152.md) | [12.9 d](/filings/0001877322-26-000007.md) | [12.5](/filings/0001877322-26-000033.md) | [13.3](/filings/0001877322-26-000056.md) |
| Selling, general and administrative | $m | [145](/filings/0001877322-24-000138.md) | [145 d](/filings/0001877322-26-000007.md) | [142](/filings/0001877322-25-000084.md) | [146](/filings/0001877322-25-000134.md) | [146](/filings/0001877322-25-000152.md) | [145 d](/filings/0001877322-26-000007.md) | [141](/filings/0001877322-26-000033.md) | [156](/filings/0001877322-26-000056.md) | [158](/filings/0001877322-25-000152.md) | [154 d](/filings/0001877322-26-000007.md) | [174](/filings/0001877322-26-000033.md) | [210](/filings/0001877322-26-000056.md) |
| Operating income | $m | [101](/filings/0001877322-24-000138.md) | [104 d](/filings/0001877322-26-000007.md) | [111](/filings/0001877322-25-000084.md) | [119](/filings/0001877322-25-000134.md) | [106](/filings/0001877322-25-000152.md) | [111 d](/filings/0001877322-26-000007.md) | [110](/filings/0001877322-26-000033.md) | [109](/filings/0001877322-26-000056.md) | [107](/filings/0001877322-25-000152.md) | [86.6 d](/filings/0001877322-26-000007.md) | [90.5](/filings/0001877322-26-000033.md) | [78.7](/filings/0001877322-26-000056.md) |
| Income tax | $m | [19.8](/filings/0001877322-24-000138.md) | [17.9 d](/filings/0001877322-26-000007.md) | [18.5](/filings/0001877322-25-000084.md) | [17.9](/filings/0001877322-25-000134.md) | [18.1](/filings/0001877322-25-000152.md) | [22.9 d](/filings/0001877322-26-000007.md) | [20.5](/filings/0001877322-26-000033.md) | [18.3](/filings/0001877322-26-000056.md) | [17.7](/filings/0001877322-25-000152.md) | [12.7 d](/filings/0001877322-26-000007.md) | [13.1](/filings/0001877322-26-000033.md) | [11.7](/filings/0001877322-26-000056.md) |
| Net income | $m | [57.6](/filings/0001877322-24-000138.md) | [50.2 d](/filings/0001877322-25-000021.md) | [60.0](/filings/0001877322-25-000084.md) | [82.9](/filings/0001877322-25-000134.md) | [68.2](/filings/0001877322-25-000152.md) | [53.7 d](/filings/0001877322-26-000007.md) | [67.4](/filings/0001877322-26-000033.md) | [66.9](/filings/0001877322-26-000056.md) | [54.8](/filings/0001877322-25-000152.md) | [37.7 d](/filings/0001877322-26-000007.md) | [47.6](/filings/0001877322-26-000033.md) | [32.4](/filings/0001877322-26-000056.md) |
| Diluted EPS | $ per share | [0.94](/filings/0001877322-24-000138.md) | not reported | [0.98](/filings/0001877322-25-000084.md) | [1.35](/filings/0001877322-25-000134.md) | [1.11](/filings/0001877322-25-000152.md) | not reported | [1.10](/filings/0001877322-26-000033.md) | [1.09](/filings/0001877322-26-000056.md) | [0.90](/filings/0001877322-25-000152.md) | not reported | [0.78](/filings/0001877322-26-000033.md) | [0.50](/filings/0001877322-26-000056.md) |
| Basic EPS | $ per share | [0.95](/filings/0001877322-24-000138.md) | not reported | [0.99](/filings/0001877322-25-000084.md) | [1.36](/filings/0001877322-25-000134.md) | [1.12](/filings/0001877322-25-000152.md) | not reported | [1.10](/filings/0001877322-26-000033.md) | [1.10](/filings/0001877322-26-000056.md) | [0.90](/filings/0001877322-25-000152.md) | not reported | [0.78](/filings/0001877322-26-000033.md) | [0.50](/filings/0001877322-26-000056.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [82.8](/filings/0001877322-23-000024.md) | [102](/filings/0001877322-25-000021.md) | [76.5](/filings/0001877322-24-000088.md) | [228](/filings/0001877322-24-000120.md) | [254](/filings/0001877322-24-000138.md) | [249](/filings/0001877322-26-000007.md) | [291](/filings/0001877322-25-000084.md) | [258](/filings/0001877322-25-000134.md) | [218](/filings/0001877322-25-000152.md) | [186](/filings/0001877322-26-000056.md) | [1,005](/filings/0001877322-26-000033.md) | [217](/filings/0001877322-26-000056.md) |
| Current assets | $m | [1,030](/filings/0001877322-23-000024.md) | [998](/filings/0001877322-25-000021.md) | [1,043](/filings/0001877322-24-000088.md) | [1,213](/filings/0001877322-24-000120.md) | [1,222](/filings/0001877322-24-000138.md) | [1,148](/filings/0001877322-26-000007.md) | [1,286](/filings/0001877322-25-000084.md) | [1,336](/filings/0001877322-25-000134.md) | [1,334](/filings/0001877322-25-000152.md) | [1,262](/filings/0001877322-26-000056.md) | [2,170](/filings/0001877322-26-000033.md) | [1,528](/filings/0001877322-26-000056.md) |
| Total assets | $m | [3,756](/filings/0001877322-23-000024.md) | [3,829](/filings/0001877322-25-000021.md) | [3,827](/filings/0001877322-24-000088.md) | [3,967](/filings/0001877322-24-000120.md) | [4,085](/filings/0001877322-24-000138.md) | [4,034](/filings/0001877322-26-000007.md) | [4,218](/filings/0001877322-25-000084.md) | [4,432](/filings/0001877322-25-000134.md) | [4,869](/filings/0001877322-25-000152.md) | [4,766](/filings/0001877322-26-000056.md) | [5,625](/filings/0001877322-26-000033.md) | [6,563](/filings/0001877322-26-000056.md) |
| Current liabilities | $m | [610](/filings/0001877322-23-000024.md) | [620](/filings/0001877322-25-000021.md) | [631](/filings/0001877322-24-000088.md) | [651](/filings/0001877322-24-000120.md) | [637](/filings/0001877322-24-000138.md) | [632](/filings/0001877322-26-000007.md) | [672](/filings/0001877322-25-000084.md) | [686](/filings/0001877322-25-000134.md) | [669](/filings/0001877322-25-000152.md) | [665](/filings/0001877322-26-000056.md) | [730](/filings/0001877322-26-000033.md) | [779](/filings/0001877322-26-000056.md) |
| Total liabilities | $m | [2,215](/filings/0001877322-23-000024.md) | [2,181](/filings/0001877322-25-000021.md) | [2,145](/filings/0001877322-24-000088.md) | [2,218](/filings/0001877322-24-000120.md) | [2,207](/filings/0001877322-24-000138.md) | [2,226](/filings/0001877322-26-000007.md) | [2,267](/filings/0001877322-25-000084.md) | [2,321](/filings/0001877322-25-000134.md) | [2,707](/filings/0001877322-25-000152.md) | [2,555](/filings/0001877322-26-000056.md) | [3,389](/filings/0001877322-26-000033.md) | [3,978](/filings/0001877322-26-000056.md) |
| Long-term debt | $m | [1,089](/filings/0001877322-23-000024.md) | [1,018](/filings/0001877322-25-000021.md) | [993](/filings/0001877322-24-000088.md) | [1,080](/filings/0001877322-24-000120.md) | [1,080](/filings/0001877322-24-000138.md) | [1,061](/filings/0001877322-26-000007.md) | [1,056](/filings/0001877322-25-000084.md) | [1,059](/filings/0001877322-25-000134.md) | [1,334](/filings/0001877322-25-000152.md) | [1,233](/filings/0001877322-26-000056.md) | [2,032](/filings/0001877322-26-000033.md) | [2,391](/filings/0001877322-26-000056.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001877322-25-000021.md) | not reported | not reported | not reported | [15.0](/filings/0001877322-26-000007.md) | [17.8](/filings/0001877322-25-000084.md) | [21.7](/filings/0001877322-25-000134.md) | [2.2](/filings/0001877322-25-000152.md) | [2.4](/filings/0001877322-26-000056.md) | [3.8](/filings/0001877322-26-000033.md) | [5.9](/filings/0001877322-26-000056.md) |
| Shareholders' equity | $m | [1,501](/filings/0001877322-23-000024.md) | [1,607](/filings/0001877322-25-000021.md) | [1,641](/filings/0001877322-24-000088.md) | [1,708](/filings/0001877322-24-000120.md) | [1,837](/filings/0001877322-24-000138.md) | [1,769](/filings/0001877322-26-000007.md) | [1,910](/filings/0001877322-25-000084.md) | [2,070](/filings/0001877322-25-000134.md) | [2,116](/filings/0001877322-25-000152.md) | [2,166](/filings/0001877322-26-000056.md) | [2,191](/filings/0001877322-26-000033.md) | [2,539](/filings/0001877322-26-000056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [107 d](/filings/0001877322-24-000138.md) | [122 d](/filings/0001877322-26-000007.md) | [44.5](/filings/0001877322-25-000084.md) | [83.0 d](/filings/0001877322-25-000134.md) | [101 d](/filings/0001877322-25-000152.md) | [127 d](/filings/0001877322-26-000007.md) | [35.4](/filings/0001877322-26-000033.md) | [46.6 d](/filings/0001877322-26-000056.md) | [81.5 d](/filings/0001877322-25-000152.md) | [97.1 d](/filings/0001877322-26-000007.md) | [46.9](/filings/0001877322-26-000033.md) | [33.4 d](/filings/0001877322-26-000056.md) |
| Capital expenditure | $m | [11.9 d](/filings/0001877322-24-000138.md) | [19.3 d](/filings/0001877322-26-000007.md) | [7.4](/filings/0001877322-25-000084.md) | [9.0](/filings/0001877322-25-000134.md) | [10.6](/filings/0001877322-25-000152.md) | [24.7 d](/filings/0001877322-26-000007.md) | [7.3](/filings/0001877322-26-000033.md) | [9.2](/filings/0001877322-25-000134.md) | [11.2](/filings/0001877322-25-000152.md) | [19.6 d](/filings/0001877322-26-000007.md) | [13.7](/filings/0001877322-26-000033.md) | [17.7 d](/filings/0001877322-26-000056.md) |
| Dividends paid | $m | [3.6 d](/filings/0001877322-24-000138.md) | [3.6 d](/filings/0001877322-26-000007.md) | [3.6](/filings/0001877322-25-000084.md) | [3.6 d](/filings/0001877322-25-000134.md) | [4.9 d](/filings/0001877322-25-000152.md) | [4.9 d](/filings/0001877322-26-000007.md) | [4.9](/filings/0001877322-26-000033.md) | [4.9 d](/filings/0001877322-26-000056.md) | [6.1 d](/filings/0001877322-25-000152.md) | [6.1 d](/filings/0001877322-26-000007.md) | [6.1](/filings/0001877322-26-000033.md) | [6.1 d](/filings/0001877322-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [60.2](/filings/0001877322-23-000024.md) | [60.5](/filings/0001877322-24-000088.md) | [60.6](/filings/0001877322-24-000120.md) | [60.7](/filings/0001877322-24-000138.md) | [61.0](/filings/0001877322-25-000084.md) | [61.1](/filings/0001877322-25-000134.md) | [61.1](/filings/0001877322-25-000152.md) | [61.3](/filings/0001877322-26-000033.md) | [61.3](/filings/0001877322-26-000056.md) | [61.2](/filings/0001877322-25-000152.md) | [61.3](/filings/0001877322-26-000033.md) | [61.6](/filings/0001877322-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 62,167,810 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001877322-26-000056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.